APA (7th ed.) Citation

KA, M., MA, N., X, Z., PR, L., S, S., SM, L., . . . DL, M. (2019). Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nature communications, 10(1), 5257. https://doi.org/10.1038/s41467-019-13151-z

Chicago Style (17th ed.) Citation

KA, Michaelis, et al. "Publisher Correction: The TLR7/8 Agonist R848 Remodels Tumor and Host Responses to Promote Survival in Pancreatic Cancer." Nature Communications 10, no. 1 (2019): 5257. https://doi.org/10.1038/s41467-019-13151-z.

MLA (9th ed.) Citation

KA, Michaelis, et al. "Publisher Correction: The TLR7/8 Agonist R848 Remodels Tumor and Host Responses to Promote Survival in Pancreatic Cancer." Nature Communications, vol. 10, no. 1, 2019, p. 5257, https://doi.org/10.1038/s41467-019-13151-z.